Comparing ultrasound-guided and blinded trigger point injections for myofascial pain
Comparison of Trigger Point Injection Application Methods in Patients With Fibromyalgia Syndrome and Myofascial Pain Syndrome
This study is testing whether ultrasound-guided trigger point injections work better than regular injections for easing pain in the neck and shoulders of people with fibromyalgia.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Firat University Academic / other |
| Locations | 1 site (Elâzığ) |
| Trial ID | NCT06555523 on ClinicalTrials.gov |
What this trial studies
This study compares the effectiveness of ultrasound-guided trigger point injections versus blinded trigger point injections in the trapezius muscle for patients with Fibromyalgia Syndrome (FMS). Seventy-five participants will be randomly assigned to receive one of the two injection types, alongside a standardized home exercise regimen focusing on stretching and posture. The effectiveness of the treatments will be assessed one month post-injection using various evaluation tools, including the Fibromyalgia Impact Questionnaire and Visual Analog Scale for pain. The goal is to deactivate trigger points and alleviate pain associated with FMS.
Who should consider this trial
Good fit: Ideal candidates are adults aged 20-60 diagnosed with Fibromyalgia Syndrome and cervical chronic myofascial pain syndrome.
Not a fit: Patients with cervical radiculopathy, systemic infections, or those who have received treatment for myofascial pain syndrome in the last three months may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide patients with more effective pain relief options for managing myofascial pain syndrome.
How similar studies have performed: Other studies have shown promise in using ultrasound guidance for trigger point injections, suggesting this approach may enhance treatment effectiveness.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 20-60 years who met the 2013 ACR criteria * Patients who will be diagnosed with FMS and cervical chronic MAS according to Travel and Simons' criteria * Patients who had a palpated tense band in the upper trapezius muscle and at least 1 active trigger point Exclusion Criteria: * Patients with a diagnosis of cervical radiculopathy, myelopathy, local or systemic infection, treatment for MAS in the last 3 months * Patients who have symptom duration less than 3 months * Patients with pregnancy status, acute or chronic disease that would cause clinical confusion at the time of the study
Where this trial is running
Elâzığ
- Songul — Elâzığ, Turkey (Türkiye) (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.